199 related articles for article (PubMed ID: 9065648)
1. Alteration of p53 gene structure and function in laryngeal squamous cell cancer.
Golusinski W; Olofsson J; Szmeja Z; Szyfter K; Szyfter W; Biczysko W; Hemminki K
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S133-7. PubMed ID: 9065648
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer.
Golusinski W; Olofsson J; Szmeja Z; Biczysko W; Krygier-Stojałowska A; Kulczyński B
Eur Arch Otorhinolaryngol; 1999; 256(6):306-11. PubMed ID: 10456281
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of p53 gene in laryngeal premalignant and malignant lesions. p53 protein immunohistochemical expression is positively related to proliferating cell nuclear antigen labelling index.
Gorgoulis V; Zoumpourlis V; Rassidakis G; Karameris A; Barbatis C; Spandidos DA; Kittas C
Virchows Arch; 1995; 426(4):339-44. PubMed ID: 7599785
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic and prognostic value of p53 oncogene and the selected neoplastic markers (Ki67, PCNA, DNA ploidy) of the ultrastructure in patients with laryngeal cancer].
Golusiński W; Szmeja Z; Olofsson J; Biczysko W; Krygier-Stojałowska A; Majewski P
Otolaryngol Pol; 1996; 50(6):607-17. PubMed ID: 9173391
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of PCNA and mutant p53 expression in laryngeal squamous cell carcinoma.
Buyukbayram H; Cureoglu S; Arslan A; Işikakdogan AR
Cancer Invest; 2004; 22(2):195-202. PubMed ID: 15199601
[TBL] [Abstract][Full Text] [Related]
6. [Experimental studies on exons 5-8 of p53 gene mutation in laryngeal squamous cell carcinoma].
Zhang X; Liu S; Zhou G; Liang C; Lin D; Qiao X
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):295-7. PubMed ID: 12545812
[TBL] [Abstract][Full Text] [Related]
7. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
8. p53 gene mutation analysis in porokeratosis and porokeratosis-associated squamous cell carcinoma.
Ninomiya Y; Urano Y; Yoshimoto K; Iwahana H; Sasaki S; Arase S; Itakura M
J Dermatol Sci; 1997 Mar; 14(3):173-8. PubMed ID: 9138474
[TBL] [Abstract][Full Text] [Related]
9. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck.
Nylander K; Nilsson P; Mehle C; Roos G
Br J Cancer; 1995 Apr; 71(4):826-30. PubMed ID: 7710950
[TBL] [Abstract][Full Text] [Related]
10. Is p53 an independent prognostic factor in patients with laryngeal carcinoma?
Narayana A; Vaughan AT; Gunaratne S; Kathuria S; Walter SA; Reddy SP
Cancer; 1998 Jan; 82(2):286-91. PubMed ID: 9445184
[TBL] [Abstract][Full Text] [Related]
11. p53, PCNA and Ki67 in laryngeal cancer.
Golusiński W; Olofsson J; Szmeja Z; Majewski P
Pol J Pathol; 1996; 47(4):175-82. PubMed ID: 9097709
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of p53 nuclear protein in premalignant and malignant laryngeal lesions.
Nakashima T; Wang XF; Masuda M; Inokuchi A; Komiyama S
Eur Arch Otorhinolaryngol; 1999; 256 Suppl 1():S56-9. PubMed ID: 10337529
[TBL] [Abstract][Full Text] [Related]
13. Association between p53 gene mutations and tobacco and alcohol exposure in laryngeal squamous cell carcinoma.
Ronchetti D; Neglia CB; Cesana BM; Carboni N; Neri A; Pruneri G; Pignataro L
Arch Otolaryngol Head Neck Surg; 2004 Mar; 130(3):303-6. PubMed ID: 15023836
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
15. Expression and mutation of the tumor suppressor gene p53 in AIDS-associated Kaposi's sarcoma.
Li JJ; Huang YQ; Cockerell CJ; Zhang WG; Nicolaides A; Friedman-Kien AE
Am J Dermatopathol; 1997 Aug; 19(4):373-8. PubMed ID: 9261472
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor p53 gene mutation in squamous cell carcinoma of the larynx.
Sarkar FH; Sakr WA; Li YW; Jacobs J; Crissman JD
Diagn Mol Pathol; 1996 Sep; 5(3):201-5. PubMed ID: 8866234
[TBL] [Abstract][Full Text] [Related]
17. Epithelial growth fraction and expression of p53 tumour suppressor gene in oral submucous fibrosis.
Cox SC; Walker DM
Aust Dent J; 1996 Apr; 41(2):91-6. PubMed ID: 8670041
[TBL] [Abstract][Full Text] [Related]
18. Cell kinetics and apoptosis in laryngeal carcinoma patients.
Georgiou A; Gomatos IP; Pararas NB; Giotakis J; Ferekidis E
Ann Otol Rhinol Laryngol; 2003 Mar; 112(3):206-13. PubMed ID: 12656410
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
20. TP53 mutations in upper aerodigestive squamous cell carcinomas from a group of Brazilian patients.
Nagai MA; Miracca EC; Yamamoto L; Kowalski LP; Brentani RR
Am J Surg; 1995 Nov; 170(5):492-4. PubMed ID: 7485740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
